JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M111975200 on January 4, 2002

J. Biol. Chem., Vol. 277, Issue 12, 10226-10235, March 22, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/12/10226    most recent
M111975200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by He, B.
Right arrow Articles by Wilson, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, B.
Right arrow Articles by Wilson, E. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The FXXLF Motif Mediates Androgen Receptor-specific Interactions with Coregulators*

Bin He, John T. Minges, Lori W. Lee, and Elizabeth M. WilsonDagger

From the Laboratories for Reproductive Biology and the Departments of Biochemistry and Biophysics, and Pediatrics, University of North Carolina, Chapel Hill, North Carolina 27599

The androgen receptor (AR) activation function 2 region of the ligand binding domain binds the LXXLL motifs of p160 coactivators weakly, engaging instead in an androgen-dependent, interdomain interaction with an FXXLF motif in the AR NH2 terminus. Here we show that FXXLF motifs are present in previously reported AR coactivators ARA70/RFG, ARA55/Hic-5, and ARA54, which account for their selection in yeast two-hybrid screens. Mammalian two-hybrid assays, ligand dissociation rate studies, and glutathione S-transferase adsorption assays indicate androgen-dependent selective interactions of these FXXLF motifs with the AR ligand binding domain. Mutagenesis of residues within activation function 2 indicates distinct but overlapping binding sites where specificity depends on sequences within and flanking the FXXLF motif. Mutagenesis of the FXXLF motifs eliminated interaction with the ligand binding domain but only modestly reduced AR coactivation in transcription assays. The studies indicate that the FXXLF binding motif is specific for the AR and mediates interactions both within the AR and with coregulatory proteins.


* This work was supported by Public Health Service Grant HD16910 from the NICHD, National Institutes of Health, by Cooperative Agreement U54-HD35041 as part of the Specialized Cooperative Centers Program in Reproductive Research of National Institutes of Health, by United States Army Medical Research and Material Command Grant DAMD17-00-1-0094, and by the International Training and Research in Population and Health Program supported by the Fogarty International Center and NICHD, National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: CB 7500, Rm. 374, Medical Sciences Research Bldg., University of North Carolina, Chapel Hill, NC 27599. Tel.: 919-966-5168; Fax: 919-966-2203; E-mail: emw@med.unc.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
S. Kaulfuss, M. Grzmil, B. Hemmerlein, P. Thelen, S. Schweyer, J. Neesen, L. Bubendorf, A. G. Glass, H. Jarry, B. Auber, et al.
Leupaxin, a Novel Coactivator of the Androgen Receptor, Is Expressed in Prostate Cancer and Plays a Role in Adhesion and Invasion of Prostate Carcinoma Cells
Mol. Endocrinol., July 1, 2008; 22(7): 1606 - 1621.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Bai and E. M. Wilson
Epidermal Growth Factor-Dependent Phosphorylation and Ubiquitinylation of MAGE-11 Regulates Its Interaction with the Androgen Receptor
Mol. Cell. Biol., March 15, 2008; 28(6): 1947 - 1963.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Bai, G. Grossman, L. Yuan, B. A. Lessey, F. S. French, S. L. Young, and E. M. Wilson
Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantation
Mol. Hum. Reprod., February 1, 2008; 14(2): 107 - 116.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Peng, C. X. Li, F. Chen, Z. Wang, M. Ligr, J. Melamed, J. Wei, W. Gerald, M. Pagano, M. J. Garabedian, et al.
Stimulation of Prostate Cancer Cellular Proliferation and Invasion by the Androgen Receptor Co-Activator ARA70
Am. J. Pathol., January 1, 2008; 172(1): 225 - 235.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. V. Heemers and D. J. Tindall
Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex
Endocr. Rev., December 1, 2007; 28(7): 778 - 808.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Cantin, F. Faucher, J.-F. Couture, K. P. de Jesus-Tran, P. Legrand, L. C. Ciobanu, Y. Frechette, R. Labrecque, S. M. Singh, F. Labrie, et al.
Structural Characterization of the Human Androgen Receptor Ligand-binding Domain Complexed with EM5744, a Rationally Designed Steroidal Ligand Bearing a Bulky Chain Directed toward Helix 12
J. Biol. Chem., October 19, 2007; 282(42): 30910 - 30919.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. B. Askew, R. T. Gampe Jr., T. B. Stanley, J. L. Faggart, and E. M. Wilson
Modulation of Androgen Receptor Activation Function 2 by Testosterone and Dihydrotestosterone
J. Biol. Chem., August 31, 2007; 282(35): 25801 - 25816.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
M. E. van Royen, S. M. Cunha, M. C. Brink, K. A. Mattern, A. L. Nigg, H. J. Dubbink, P. J. Verschure, J. Trapman, and A. B. Houtsmuller
Compartmentalization of androgen receptor protein-protein interactions in living cells
J. Cell Biol., April 9, 2007; 177(1): 63 - 72.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. M. Wilson
Muscle-Bound? A Tissue-Selective Nonsteroidal Androgen Receptor Modulator
Endocrinology, January 1, 2007; 148(1): 1 - 3.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Folkertsma, P. I. van Noort, A. de Heer, P. Carati, R. Brandt, A. Visser, G. Vriend, and J. de Vlieg
The Use of in Vitro Peptide Binding Profiles and in Silico Ligand-Receptor Interaction Profiles to Describe Ligand-Induced Conformations of the Retinoid X Receptor {alpha} Ligand-Binding Domain
Mol. Endocrinol., January 1, 2007; 21(1): 30 - 48.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
C. J Burd, L. M Morey, and K. E Knudsen
Androgen receptor corepressors and prostate cancer
Endocr. Relat. Cancer, December 1, 2006; 13(4): 979 - 994.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Z. Lu, S. E. Wardell, K. L. Burnstein, D. Defranco, P. J. Fuller, V. Giguere, R. B. Hochberg, L. McKay, J.-M. Renoir, N. L. Weigel, et al.
International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 782 - 797.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Dehm and D. J. Tindall
Ligand-independent Androgen Receptor Activity Is Activation Function-2-independent and Resistant to Antiandrogens in Androgen Refractory Prostate Cancer Cells
J. Biol. Chem., September 22, 2006; 281(38): 27882 - 27893.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. J. Dubbink, R. Hersmus, A. C. W. Pike, M. Molier, A. O. Brinkmann, G. Jenster, and J. Trapman
Androgen Receptor Ligand-Binding Domain Interaction and Nuclear Receptor Specificity of FXXLF and LXXLL Motifs as Determined by L/F Swapping
Mol. Endocrinol., August 1, 2006; 20(8): 1742 - 1755.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. van de Wijngaart, M. E. van Royen, R. Hersmus, A. C. W. Pike, A. B. Houtsmuller, G. Jenster, J. Trapman, and H. J. Dubbink
Novel FXXFF and FXXMF Motifs in Androgen Receptor Cofactors Mediate High Affinity and Specific Interactions with the Ligand-binding Domain
J. Biol. Chem., July 14, 2006; 281(28): 19407 - 19416.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Li, J. Fu, C. Toumazou, H.-G. Yoon, and J. Wong
A Role of the Amino-Terminal (N) and Carboxyl-Terminal (C) Interaction in Binding of Androgen Receptor to Chromatin
Mol. Endocrinol., April 1, 2006; 20(4): 776 - 785.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Estebanez-Perpina, J. M. R. Moore, E. Mar, E. Delgado-Rodrigues, P. Nguyen, J. D. Baxter, B. M. Buehrer, P. Webb, R. J. Fletterick, and R. K. Guy
The Molecular Mechanisms of Coactivator Utilization in Ligand-dependent Transactivation by the Androgen Receptor
J. Biol. Chem., March 4, 2005; 280(9): 8060 - 8068.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Bai, B. He, and E. M. Wilson
Melanoma Antigen Gene Protein MAGE-11 Regulates Androgen Receptor Function by Modulating the Interdomain Interaction
Mol. Cell. Biol., February 15, 2005; 25(4): 1238 - 1257.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C.-L. Hsu, Y.-L. Chen, H.-J. Ting, W.-J. Lin, Z. Yang, Y. Zhang, L. Wang, C.-T. Wu, H.-C. Chang, S. Yeh, et al.
Androgen Receptor (AR) NH2- and COOH-Terminal Interactions Result in the Differential Influences on the AR-Mediated Transactivation and Cell Growth
Mol. Endocrinol., February 1, 2005; 19(2): 350 - 361.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. C. Brown and C. E. Turner
Paxillin: Adapting to Change
Physiol Rev, October 1, 2004; 84(4): 1315 - 1339.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. J. Dubbink, R. Hersmus, C. S. Verma, H. A. G. M. van der Korput, C. A. Berrevoets, J. van Tol, A. C. J. Ziel-van der Made, A. O. Brinkmann, A. C. W. Pike, and J. Trapman
Distinct Recognition Modes of FXXLF and LXXLL Motifs by the Androgen Receptor
Mol. Endocrinol., September 1, 2004; 18(9): 2132 - 2150.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
G. Buchanan, M. Yang, A. Cheong, J. M. Harris, R. A. Irvine, P. F. Lambert, N. L. Moore, M. Raynor, P. J. Neufing, G. A. Coetzee, et al.
Structural and functional consequences of glutamine tract variation in the androgen receptor
Hum. Mol. Genet., August 15, 2004; 13(16): 1677 - 1692.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-C. Hu, S. Yeh, S.-D. Yeh, E. R. Sampson, J. Huang, P. Li, C.-L. Hsu, H.-J. Ting, H.-K. Lin, L. Wang, et al.
Functional Domain and Motif Analyses of Androgen Receptor Coregulator ARA70 and Its Differential Expression in Prostate Cancer
J. Biol. Chem., August 6, 2004; 279(32): 33438 - 33446.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. He, S. Bai, A. T. Hnat, R. I. Kalman, J. T. Minges, C. Patterson, and E. M. Wilson
An Androgen Receptor NH2-terminal Conserved Motif Interacts with the COOH Terminus of the Hsp70-interacting Protein (CHIP)
J. Biol. Chem., July 16, 2004; 279(29): 30643 - 30653.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Wang, C.-L. Hsu, J. Ni, P.-H. Wang, S. Yeh, P. Keng, and C. Chang
Human Checkpoint Protein hRad9 Functions as a Negative Coregulator To Repress Androgen Receptor Transactivation in Prostate Cancer Cells
Mol. Cell. Biol., March 1, 2004; 24(5): 2202 - 2213.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. W. Gregory, X. Fei, L. A. Ponguta, B. He, H. M. Bill, F. S. French, and E. M. Wilson
Epidermal Growth Factor Increases Coactivation of the Androgen Receptor in Recurrent Prostate Cancer
J. Biol. Chem., February 20, 2004; 279(8): 7119 - 7130.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Sathya, C.-y. Chang, D. Kazmin, C. E. Cook, and D. P. McDonnell
Pharmacological Uncoupling of Androgen Receptor-mediated Prostate Cancer Cell Proliferation and Prostate-specific Antigen Secretion
Cancer Res., November 15, 2003; 63(22): 8029 - 8036.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Kasai, J. Guerrero-Santoro, R. Friedman, E. S. Leman, R. H. Getzenberg, and D. B. DeFranco
The Group 3 LIM Domain Protein Paxillin Potentiates Androgen Receptor Transactivation in Prostate Cancer Cell Lines
Cancer Res., August 15, 2003; 63(16): 4927 - 4935.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-L. Hsu, Y.-L. Chen, S. Yeh, H.-J. Ting, Y.-C. Hu, H. Lin, X. Wang, and C. Chang
The Use of Phage Display Technique for the Isolation of Androgen Receptor Interacting Peptides with (F/W)XXL(F/W) and FXXLY New Signature Motifs
J. Biol. Chem., June 20, 2003; 278(26): 23691 - 23698.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G.-Z. Liu, H. Wang, and Z. Wang
Identification of a Highly Conserved Domain in the Androgen Receptor That Suppresses the DNA-binding Domain-DNA Interactions
J. Biol. Chem., April 18, 2003; 278(17): 14956 - 14960.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. He and E. M. Wilson
Electrostatic Modulation in Steroid Receptor Recruitment of LXXLL and FXXLF Motifs
Mol. Cell. Biol., March 15, 2003; 23(6): 2135 - 2150.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Li, H. Lee, S. Guo, T. G. Unterman, G. Jenster, and W. Bai
AKT-Independent Protection of Prostate Cancer Cells from Apoptosis Mediated through Complex Formation between the Androgen Receptor and FKHR
Mol. Cell. Biol., January 1, 2003; 23(1): 104 - 118.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. He, L. W. Lee, J. T. Minges, and E. M. Wilson
Dependence of Selective Gene Activation on the Androgen Receptor NH2- and COOH-terminal Interaction
J. Biol. Chem., July 5, 2002; 277(28): 25631 - 25639.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. P. Gelmann
Molecular Biology of the Androgen Receptor
J. Clin. Oncol., July 1, 2002; 20(13): 3001 - 3015.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.